NCT00161941View on ClinicalTrials.gov

Follow-up Study on the Antibody Response to Hepatitis B, Acellular Pertussis Toxin and Inactivated Poliovirus Antigens 1 Month After the 4th Hexavac® Vaccination in Healthy Children, Who Participated in NeisVac-C Study 216

CompletedOBSERVATIONAL
Enrollment

321

Participants

Timeline

Start Date

June 30, 2003

Study Completion Date

December 31, 2003

Conditions
Meningococcal Meninigitis, Serogroup C
Trial Locations (11)

4600

Grieskirchner Strasse 17, Wels

74072

Solothurner Strasse 2, Heilbronn

74321

Hauptrasse 9, Bietigheim-Bissingen

77694

Hauptrasse 240, Kehl

77955

Rheinstrasse13, Ettenheim

78713

Berneckstrasse 19, Schrammberg

78727

Tuchbergstrass 2, Oberndorf / Neckar

86163

Neuschwansteinstrasse 5, Augsburg

86720

Löpsinger Strasse 8, Nördlingen

88348

Marktplatz 3, Bad Saulgau

93426

Falkensteiner Str. 24, Roding

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY